Intact 5-HT2A receptor exons and the adjoining intron regions in schizophrenia

Neuropsychopharmacology

Volumn 14, Issue 5, 1996, Pages 339-347

  Ishigaki, Tatsuya ^a   Xie, Dar Win ^a   Liu, Jian Cheng ^a   Nakamura, Yuhei ^a   Zhang, Hai Yin ^c   Tani, Kunihiko ^a   Shimazu, Yoshihiro ^a   Chen, Kevin ^b   Shih, Jean C ^b   Miyasato, Katsumasa ^a   Ohara, Kenshiro ^a   Ohara, Koichi ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

5 ht2a receptor; Polymerase chain reaction; Polymorphism; Restriction fragment length polymorphism; Schizophrenia; Single strand conformation polymorphism

Indexed keywords

SEROTONIN 2A RECEPTOR; SEROTONIN RECEPTOR; DNA;

ADULT; AMINO ACID SEQUENCE; ARTICLE; COMPARATIVE STUDY; EXON; FEMALE; GENETICS; HUMAN; INTRON; MALE; MIDDLE AGED; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCHIZOPHRENIA; SINGLE STRAND CONFORMATION POLYMORPHISM; CONTROLLED STUDY; DNA SEQUENCE; GENETIC POLYMORPHISM; GENOME; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECEPTOR GENE; SEROTONINERGIC SYSTEM;

ADULT; AMINO ACID SEQUENCE; BASE SEQUENCE; EXONS; FEMALE; HUMANS; INTRONS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, SEROTONIN; SCHIZOPHRENIA;

EID: 0029666203     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0893-133X(95)00143-2     Document Type: Article

References (46)

1. American Psychiatric Association (1994): Diagnostic and Statistical Manual of Mental Disorders, ed 4, Washington, DC, American Psychiatric Association
2. 2) receptor binding in the frontal cortex of schizophrenic patients. J Neural Transm 85:19-29
3. 2 receptor is encoded by multiple intron-exon gene. Mol Brain Res 14:20-26
4. Claus A, Bollen J, De Cuyper H, Eneman M, Malfroid M, Peuskens J, Heylen S (1992): Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: A multicentre double-blind comparative study. Acta Psychiatr Scand 85:295-305
5. Creese I, Burt DR, Snyder SH (1976): Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192:481-483
6. Crow TJ (1980a): Molecular pathology of schizophrenia: More than one disease process? Br Med J 280:66-68.
7. Crow TJ (1980b): Positive and negative schizophrenic symptoms and the role of dopamine. Br J Psychiatry 137:383-386
8. 2 receptor gene: Selective reactivation of a repressed promotor. Mol Brain Res 20:181-191
9. 2/1C antagonist, and negative symptoms in schizophrenia: A placebo-controlled double-blind trial. Br J Psychiatr 163: 451-455
10. 2 receptor and schizophrenia in a large Swedish kindred. Arch Gen Psychiatr 49:216-219
11. Hayashi K (1991): PCR-SSCP: A simple and sensitive method for detection of mutations in the genomic DNA. PCR Meth Appl 1:34-38
12. Hongyo T, Buzard GS, Calvert RJ, Weghorst CM (1993): "Cold SSCP": A simple, rapid and nonradioactive method for optimized single-strand conformation polymorphism analyses. Nucl Acids Res 21:3637-3642
13. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PPA (1994): Seventh international union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46:157-203
14. Hsiao JK, Colison J, Bartko JJ, Doran AR, Konicki PE, Potter WZ, Pickar D (1993): Monoamine neurotransmitter interactions in drug-free and neuroleptic-treated schizophrenics. Arch Gen Psyciatr 50:606-614
15. Hsieh C-L, Bowcock AM, Farrer LA, Hebert JM, Huang KN, Cavalli-Sforza LL, Julius D, Francke U (1990): The serotonin receptor subtype 2 locus HTR2 is on human chromosome 13 near genes for esterase D and retinoblastoma-1 and on mouse chromosome 14. Somat Cell Mol Genet 16:567-574
16. Humphrey PPA, Hartig P, Hoyer D (1993): A proposed new nomenclature for 5-HT receptors. Trends Pharmacol Sci 14:233-236
17. Joyce JN (1993): The dopamine hypothesis of schizophrenia: Limbic interactions with serotonin and norepinephrine. Psychopharmacology 112:S16-S34
18. Joyce JN, Shane A, Lexow N, Winokur A, Casanova MF, Kleinman JE (1993): Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics. Neuropsychopharmacology 8:315-336
19. Julius D (1991): Molecular biology of serotonin receptors. Ann Rev Neurosci 14:335-360
20. 2 receptor defines a family of structurally distinct but functionally conserved serotonin receptors. Proc Natl Acad Sci U S A 87:928-932
21. Kahn RS, Davidson M, Knott P, Stern RG, Apter S, Davis KL (1993): Effect of neuroleptic medication on cerebrospinal fluid monoamine metabolite concentrations in schizophrenia. Arch Gen Psychiatr 50:599-605
22. Kane J, Honigfeld G, Singer J, Meltzer HY (1988): Clozapine for the treatment-resistant schizophrenics: A double-blind comparison with chlorpromazine. Arch Gen Psychiatr 45:789-796
23. Kay SR, Opler LA, Fiszbein A (1991): Positive and Negative Syndrome Scale (PANSS) Rating Manual, Toronto, Multi-Health Systems Inc.
24. Laruelle M, Abi-Dargham A, Casanova MF, Toti R, Weinberger DR, Kleinman JE (1993): Selective abnormalities of prefrontal serotonergic receptors in schizophrenia: A postmortem study. Arch Gen Psychiatr 50:810-818
25. Leysen JE, Niemegeers CJE, Tollenaere JP, Laduron PM (1978): Serotonergic component of neuroleptic receptors. Nature 272:168-171
26. Leysen JE, Janssen PMF, Megens AAHP, Schotte A (1994): Risperidone: A novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity. J Clin Psychiatr 55(suppl): 5-12
27. Meltzer HY (1989): Clinical studies on the mechanism of action of clozapine: The dopamine-serotonin hypothesis of schizophrenia. Psychopharmacol 99:S18-S27
28. Meltzer HY (1992): The importance of serotonin-dopamine interactions in the action of clozapine. Br J Psychiatr 160(suppl 17):S22-S29
29. 2 pKi values. J Pharmacol Exp Ther 251:238-246
30. 2 receptors in chronic schizophrenics. Biol Psychiatr 21:1407-1414
31. 2 receptor occupancy in clozapine-treated patients demonstrated by PET. Psychopharmacol 110:365-367
32. 2 dopamine receptor occupancy in the living human brain. Psychopharmacol 110:265-272
33. Ohuoha DC, Hyde TM, Kleinman JE (1993): The role of serotonin in schizophrenia: An overview of the nomenclature, distribution and alterations of serotonin receptors in the central nervous system. Psychopharmacology 112:55-515
34. Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T (1989): Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci U S A 86:2766-2770
35. Oto M, Miyake S, Yuasa Y (1993): Optimization of nonradioisotopic single strand conformation polymorphism analysis with a conventional minislab gel electrophoresis apparatus. Anal Biochem 213:19-22
36. 2 receptors and their involvement in schizophrenia and neuroleptic drug action. J Neural Transm 18(suppl):273-277
37. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn GT, Mullis KB, Erlich HA (1988): Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487-491
38. 1C receptor subtypes. Biochem Biophys Res Commun 181:1469-1478
39. Sanger F, Nicklen S, Coulson AR (1977): DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A 74:5463-5467
40. Seeman P, Lee T, Wang C-M, Wong K (1976): Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 261:717-719
41. Toth M, Shenk T (1994): Antagonist-mediated downregulation of 5-hydroxytryptamine type 2 receptor gene expression: Modulation of transcription. Mol Pharmacol 45:1095-1100
42. Toru M (1984): Seishinbunretsubyo no yakuri [Pharmacology in Schizophrenia], Tokyo, Chu-Gai Igakusha Co.
43. Wang L, Hirayasu K, Ishizawa M, Kobayashi Y (1994): Purification of genomic DNA from human whole blood by isopropanol-fractionation with concentrated NaI and SDS. Nucl Acids Res 22:1774-1775
44. 2): Detection by DGGE and RFLP analysis. Hum Mol Genet 2:338
45. Watson S, Girdlestone D (1994): 1994 Receptor and Ion Channel Nomenclature Supplement, ed 5, New York, Elsevier
46. Winship PR (1989): An improved method for directly sequencing PCR amplified material using dimethyl sulphoxide. Nucl Acids Res 17:1266